A panel of experts, including Dr Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung ...

This blog describes a typical ILD patient journey from the initial diagnosis through its long-term management to end-of-life ...

BackgroundIdiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease characterized by unexplained ...

Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic ...

A research group from Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences ...

Considering taking supplements to treat idiopathic interstitial pneumonia? Below is a list of common natural remedies used to treat or reduce the symptoms of idiopathic interstitial pneumonia.

The Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

IPF is a rare progressive fibrosing interstitial lung disease with symptoms that include breathing difficulty, dry and persistent cough, chest discomfort and fatigue. The randomized, double-blind, ...

for the treatment of idiopathic pulmonary fibrosis (IPF). IPF is a rare progressive fibrosing interstitial lung disease with symptoms that include breathing difficulty, dry and persistent cough ...